Passiflora foetida, commonly known as "stinking passionflower," is a medicinal plant with a long history of traditional use in various cultures for its therapeutic properties. This review provides an overview of the pharmacognostical and pharmacological characteristics of Passiflora foetida, highlighting its potential as a valuable source of bioactive compounds for pharmaceutical and nutraceutical applications. Pharmacognostical studies of Passiflora foetida encompass its morphological, anatomical, and chemical composition. Macroscopic and microscopic examinations reveal distinctive features such as the presence of glandular trichomes, characteristic floral structures, and specific secondary metabolites including flavonoids, alkaloids, and phenolic compounds. These features aid in the identification and quality control of Passiflora foetida plant material. Pharmacological investigations have demonstrated a wide range of biological activities associated with Passiflora foetida extracts and isolated compounds. These include anti-inflammatory, analgesic, antioxidant, antimicrobial, antidiabetic, and neuropharmacological effects, among others. Mechanistic studies have revealed the involvement of various molecular targets and pathways, supporting its traditional use in managing diverse health conditions. Furthermore, the safety profile of Passiflora foetida has been evaluated, with limited reports of adverse effects at recommended doses. However, further toxicological studies are warranted to fully assess its safety profile and potential interactions with other medications. In conclusion, Passiflora foetida exhibits promising pharmacognostical and pharmacological properties, validating its traditional use as a medicinal plant. Future research should focus on elucidating its mechanisms of action, exploring potential therapeutic applications, and standardizing extraction methods to harness its full therapeutic potential.